Oncology Biomarker Testing Current US Practice Baseline and Emerging Trends
Julia Trosman, Center for Business Models in Healthcare, speaking at Diagnostics & Biomarkers 2015.
Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM)
Jani Saarela, Institute for Molecular Medicine, speaking at Screening Europe 2015
Development of a Point-of-Care Diagnostic for Influenza Detection with Antiviral Treatment Effectiveness Indication
Richard Murdock, USAF, speaking at Point of Care Diagnostics 2015
Romantic Surfaces and Microbial Capture
Han Zuilhof, Wageningen University, speaking at Biodetection & Biosensors 2015
Detecting Single DNA Molecules with Optical Microcavities
Frank Vollmer, Max Planck Institute for the Science of Light, speaking at Biodetection & Biosensors 2015
15 Years HCS: Next Gen Screening Devices Learn from Each Other. Literally. Fast Workflow Development & BigData Image Analytics Used to be a Challenge. What’s Next?
Urban Liebel, ACQUIFER, speaking at Screening Europe 2015
Imaging Biomarkers - Future or Reality
Edwin van Beek, University of Edinburgh, speaking at Diagnostics & Biomarkers 2015.
High-Throughput Approaches to Cell Biology
Robin Ketteler, University College London, speaking at Screening Europe 2015.
Fragment-based Approach to Multi-target Compounds
Eugen Proschak, Goethe University, speaking at Discovery Chemistry Congress 2015.
Selection of Label-free Cellular Imaging Applications for their Integration in the Screening Strategy
Gerardo Turcatti, Ecole Polytechnique Federale De Lausanne, speaking at Screening Europe 2015.
|<<|| 1 2 3 4 5 6 7 || >>|
|Showing Results 1 - 10 of 271|